SMC:NYSESummit Midstream Corporation Analysis
Data as of 2026-09-01 - not real-time
$34.72
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At $34.72, Summit Midstream Corporation shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 13.4%. RSI sits at 64.5, which reads as approaching overbought, and MACD momentum is bearish. Recent trading has carved out support near $29.97 and resistance around $36.47.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 35.4% above today's level. Revenue is growing at 10.6% on a -3.5% profit margin.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 33.5%, a beta of 0.33 and a maximum drawdown of 18.3%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 35.4% above today's level. Revenue is growing at 10.6% on a -3.5% profit margin.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 33.5%, a beta of 0.33 and a maximum drawdown of 18.3%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Top Market Events
Summit Midstream SMC that its Board continued to suspend cash dividends payable on the common stock for the period...Updated Jul 30, 2026 0 HOUSTON, July 30, 2026 /PRNewswire/ -- Summit Midstream Corporation NYSE: SMC "Summit", "SMC" or...EBITDA rose 12% in Rockies and Mid-Con; management eyes 3.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 29.41
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 29.41
- Analyst targets imply +35.4% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -3.5%
- Analyst targets imply +35.4% versus the current price
- Negative return on equity of -2.9%
Key Metrics & Analysis
Financial Health
Revenue Growth10.60%
Profit Margin-3.55%
P/E Ratio-14.8
ROE-2.92%
ROA2.37%
Debt/Equity134.91
P/B Ratio0.9
Op. Cash Flow$131.2M
Free Cash Flow$-3568875
Industry P/E21.7
Technical Analysis
TrendBullish
RSI64.5
Support$29.97
Resistance$36.47
MA 20$33.71
MA 50$31.50
MA 200$29.41
MACDBearish
VolumeDecreasing
Fear & Greed Index93.66
Valuation
Fair Value$43.92
Target Price$47.00
Upside/Downside35.37%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.33
Volatility33.51%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKWTS
Watts Water Technologies, Inc.
STOCKAMZN
Amazon.com, Inc.
STOCKBLK
BlackRock, Inc.
STOCKUSFD
US Foods Holding Corp.
STOCKUSAC
USA Compression Partners, LP
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.